Marlene Schmitz

NPI: 1790937498
Total Payments
$3,503
2024 Payments
$1,161
Companies
55
Transactions
201
Medicare Patients
265
Medicare Billing
$19,391

Payment Breakdown by Category

Food & Beverage$3,476 (99.2%)
Other$27.78 (0.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,476 199 99.2%
Debt forgiveness $27.78 2 0.8%

Top Paying Companies

Company Total Records Latest Year
Janssen Biotech, Inc. $238.91 16 $0 (2024)
Pharmacosmos Therapeutics Inc. $216.59 5 $0 (2024)
ABBVIE INC. $190.76 13 $0 (2024)
Merck Sharp & Dohme LLC $187.49 11 $0 (2024)
Incyte Corporation $168.32 5 $0 (2024)
Amgen Inc. $140.03 8 $0 (2023)
Daiichi Sankyo Inc. $124.68 8 $0 (2024)
AstraZeneca Pharmaceuticals LP $122.71 7 $0 (2024)
Novartis Pharmaceuticals Corporation $122.45 7 $0 (2024)
Seagen Inc. $117.33 7 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,161 62 Incyte Corporation ($123.94)
2023 $1,194 63 Pharmacosmos Therapeutics Inc. ($143.44)
2022 $568.94 37 Janssen Biotech, Inc. ($64.29)
2021 $579.98 39 Merck Sharp & Dohme Corporation ($59.28)

All Payment Transactions

201 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/17/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $17.73 General
Category: ONCOLOGY
12/12/2024 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage Cash or cash equivalent $23.33 General
Category: ONCOLOGY
11/12/2024 ARRAY BIOPHARMA INC BRAFTOVI (Drug), MEKTOVI, TUKYSA Food and Beverage In-kind items and services $17.27 General
Category: ONCOLOGY
10/31/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $16.56 General
Category: ONCOLOGY
10/23/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $20.87 General
Category: ONCOLOGY
10/21/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $17.56 General
Category: Oncology
10/15/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $19.00 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
10/14/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $17.45 General
Category: Hematology
10/11/2024 Janssen Biotech, Inc. DARZALEX (Biological) Food and Beverage In-kind items and services $16.84 General
Category: Oncology
10/03/2024 Takeda Pharmaceuticals U.S.A., Inc. NINLARO (Drug) Food and Beverage In-kind items and services $18.70 General
Category: ONCOLOGY
10/02/2024 Pharmacosmos Therapeutics Inc. COSELA (Drug) Food and Beverage In-kind items and services $21.62 General
Category: HEMATOLOGY
09/28/2024 PharmaEssentia USA Corporation BESREMI (Drug) Food and Beverage In-kind items and services $15.34 General
Category: Oncology
09/26/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $14.70 General
Category: Hematology
09/24/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $18.39 General
Category: Oncology
09/12/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $18.78 General
Category: Acute Myeloid Leukemia
09/06/2024 TerSera Therapeutics LLC Xermelo (Drug) Food and Beverage In-kind items and services $22.15 General
Category: Oncology
08/29/2024 TAIHO ONCOLOGY, INC. LONSURF (Drug), INQOVI Food and Beverage In-kind items and services $19.07 General
Category: Oncology
08/22/2024 Genentech USA, Inc. Alecensa (Biological), Tecentriq Food and Beverage In-kind items and services $14.39 General
Category: BioOncology
08/15/2024 Blueprint Medicines Corporation AYVAKIT (Drug) Food and Beverage Cash or cash equivalent $18.13 General
Category: Oncology / Rare Diseases
08/08/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $16.94 General
Category: Oncology
08/07/2024 SOBI, INC GAMIFANT (Drug) Food and Beverage In-kind items and services $14.83 General
Category: HEMATOLOGY
08/07/2024 Novartis Pharmaceuticals Corporation SCEMBLIX (Drug) Food and Beverage In-kind items and services $14.61 General
Category: Oncology
07/25/2024 GlaxoSmithKline, LLC. OJJAARA (Drug) Food and Beverage In-kind items and services $19.83 General
Category: ONCOLOGY
07/03/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $19.00 General
Category: Oncology
06/27/2024 Boehringer Ingelheim Pharmaceuticals, Inc. GILOTRIF (Drug) Food and Beverage In-kind items and services $15.18 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 69 142 $21,430 $4,893
2022 2 73 159 $19,070 $4,057
2021 2 50 109 $18,985 $4,132
2020 3 73 116 $26,611 $6,309
Total Patients
265
Total Services
526
Medicare Billing
$19,391
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 44 87 $20,880 $4,829 23.1%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2023 25 55 $550.00 $64.22 11.7%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 41 76 $18,240 $3,945 21.6%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2022 32 83 $830.00 $112.07 13.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 38 74 $17,760 $3,982 22.4%
85610 Blood test, clotting time Office 2021 12 35 $1,225 $150.15 12.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 34 67 $16,080 $3,549 22.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 26 35 $8,611 $1,970 22.9%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 13 14 $1,920 $789.04 41.1%

About Marlene Schmitz

Marlene Schmitz is a Adult Health healthcare provider based in Springfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2008. The National Provider Identifier (NPI) number assigned to this provider is 1790937498.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marlene Schmitz has received a total of $3,503 in payments from pharmaceutical and medical device companies, with $1,161 received in 2024. These payments were reported across 201 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($3,476).

As a Medicare-enrolled provider, Schmitz has provided services to 265 Medicare beneficiaries, totaling 526 services with total Medicare billing of $19,391. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Adult Health
  • Location Springfield, NJ
  • Active Since 10/14/2008
  • Last Updated 05/20/2019
  • Taxonomy Code 363LA2200X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1790937498

Products in Payments

  • KEYTRUDA (Biological) $187.49
  • MONOFERRIC (Drug) $158.37
  • DARZALEX (Biological) $139.07
  • VENCLEXTA (Drug) $134.64
  • Lenvima (Drug) $113.29
  • Enhertu (Drug) $108.01
  • PEMAZYRE (Drug) $103.83
  • XARELTO (Drug) $88.61
  • LONSURF (Drug) $83.68
  • SCEMBLIX (Drug) $79.36
  • Nubeqa (Drug) $78.22
  • BRUKINSA (Drug) $77.53
  • TUKYSA (Drug) $76.64
  • IMBRUVICA (Drug) $73.72
  • JAKAFI (Drug) $64.49
  • LUMAKRAS (Drug) $63.36
  • OPDIVO (Biological) $61.98
  • clonoSEQ (Device) $60.84
  • OXBRYTA (Drug) $57.38
  • NINLARO (Drug) $55.76

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Adult Health Doctors in Springfield